Tomotoshi Marumoto
Overview
Explore the profile of Tomotoshi Marumoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
2280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nii T, Kohara H, Marumoto T, Sakuma T, Yamamoto T, Tani K
Biores Open Access
. 2016 Jun;
5(1):127-36.
PMID: 27257519
Efficient gene transfer into human pluripotent stem cells (hPSCs) holds great promise for regenerative medicine and pharmaceutical development. In the past decade, various methods were developed for gene transfer into...
2.
Murahashi M, Hijikata Y, Yamada K, Tanaka Y, Kishimoto J, Inoue H, et al.
Clin Immunol
. 2016 Apr;
166-167:48-58.
PMID: 27072896
We designed a phase I trial to investigate the safety, immune responses and clinical benefits of a five-peptide cancer vaccine in combination with chemotherapy. Study subjects were patients positive for...
3.
Nii T, Marumoto T, Kohara H, Yamaguchi S, Kawano H, Sasaki E, et al.
Exp Hematol
. 2015 Jun;
43(10):901-911.e4.
PMID: 26073521
Hematopoietic stem/progenitor cells (HSPCs) derived from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have potential therapeutic applications in humans. To assess the safety and efficacy of ESC/iPSC-based...
4.
Nii T, Marumoto T, Kawano H, Yamaguchi S, Liao J, Okada M, et al.
FEBS Open Bio
. 2014 Mar;
4:213-9.
PMID: 24649403
Common marmoset (CM) is widely recognized as a useful non-human primate for disease modeling and preclinical studies. Thus, embryonic stem cells (ESCs) derived from CM have potential as an appropriate...
5.
Yamaguchi S, Marumoto T, Nii T, Kawano H, Liao J, Nagai Y, et al.
Cancer Sci
. 2014 Feb;
105(4):402-8.
PMID: 24521492
Recent generation of induced pluripotent stem (iPSCs) has made a significant impact on the field of human regenerative medicine. Prior to the clinical application of iPSCs, testing of their safety...
6.
Liao J, Marumoto T, Yamaguchi S, Okano S, Takeda N, Sakamoto C, et al.
Mol Ther
. 2013 Apr;
21(6):1242-50.
PMID: 23568261
Induced pluripotent stem cells (iPSCs) can be generated from patients with specific diseases by the transduction of reprogramming factors and can be useful as a cell source for cell transplantation...
7.
Friedmann-Morvinski D, Bushong E, Ke E, Soda Y, Marumoto T, Singer O, et al.
Science
. 2012 Oct;
338(6110):1080-4.
PMID: 23087000
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in humans. Here we show that gliomas can originate from differentiated cells in the central nervous system...
8.
Nii T, Marumoto T, Tani K
J Biomed Biotechnol
. 2012 Jul;
2012:903435.
PMID: 22778557
Hematopoietic stem cells (HSCs) have the capacity to self-renew as well as to differentiate into all blood cell types, and they can reconstitute hematopoiesis in recipients with bone marrow ablation....
9.
Hijikata Y, Murahashi-Iga M, Okazaki T, Tanaka Y, Odaira K, Okano S, et al.
Rinsho Ketsueki
. 2012 Jun;
53(5):487-92.
PMID: 22728549
No abstract available.
10.
Marumoto T, Saya H
Adv Exp Med Biol
. 2012 May;
746:2-11.
PMID: 22639155
Glioblastoma (GBM) is the most aggressive form of glioma. Despite ceaseless efforts by researchers and physicians to find new therapeutic strategies, there have been no significant advances in the treatment...